|
1.
|
原著(症例報告除く)
|
Effect of Double Layer Polyglycolic Acid Felt for Reducing Pancreatic Fistula After Pancreatoduodenectomy: Results of a Multicenter Randomized Control Trial (PLANET-PJ trial). 2026/03
|
|
2.
|
総説
|
The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer. 2026/03
|
|
3.
|
原著(症例報告除く)
|
Clinicopathological Factors on Survival after Conversion Surgery for Unresectable Locally Advanced Pancreatic Cancer: A Nationwide Study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. 2026/01
|
|
4.
|
原著(症例報告除く)
|
Neoadjuvant Chemotherapy with Gemcitabine and S-1 versus Upfront Surgery for Resectable Pancreatic Cancer: Results of the Randomized Phase II/III Prep-02/JSAP05 Trial 2026/01
|
|
5.
|
原著(症例報告除く)
|
Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed Using a Time-Dependent Cox Regression Model. 2026/01
|
|
6.
|
その他
|
治療法の再整理とアップデートのために 専門家による私の治療 膵神経内分泌腫瘍(pNET) 2026/01
|
|
7.
|
原著(症例報告除く)
|
Long-term outcomes of prophylactic right-half dissection of the superior mesenteric artery nerve plexus in pancreatoduodenectomy for pancreatic ductal adenocarcinoma: five-year results from a randomized phase II trial. 2025/11
|
|
8.
|
原著(症例報告除く)
|
Comparison between Neoadjuvant Chemoradiotherapy and Chemotherapy for Patients with Resectable Pancreatic Cancer. 2025/10
|
|
9.
|
原著(症例報告除く)
|
Comparison of clinical features by primary site in patients with biliary tract cancer who received gemcitabine-based chemotherapy: an exploratory analysis of JCOG1113. 2025/10
|
|
10.
|
原著(症例報告除く)
|
Development and Validation of the SDLD-Score: a Simplified Tool to Predict Successful Endoscopic Papillectomy in Ampullary Lesions. 2025/10
|
|
11.
|
原著(症例報告除く)
|
Favorable Response Defined by CA19-9 Reduction After Neoadjuvant Treatment for Pancreatic Cancer. 2025/09
|
|
12.
|
原著(症例報告除く)
|
Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Cancer. 2025/08
|
|
13.
|
原著(症例報告除く)
|
Mesenteric Versus Conventional Approach During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma (MAPLE-PD trial): A Multicenter Randomized Controlled Trial. 2025/08
|
|
14.
|
原著(症例報告除く)
|
Patients With Pancreatic Cancer With Synchronous Liver Oligometastasis Show a Significant Long-Term Survival Benefit From Resection Under Specific Conditions: A Multicenter National Cohort Study. 2025/08
|
|
15.
|
原著(症例報告除く)
|
Global survey on surgeon preference and current practice for pancreatic neck and body cancer with portomesenteric venous involvement 2025/07
|
|
16.
|
原著(症例報告除く)
|
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study. 2025/07
|
|
17.
|
その他
|
【よくわかる膵体尾部切除術】脾温存膵体尾部切除術 低侵襲手術時代における開腹脾温存膵体尾部切除術 2025/07
|
|
18.
|
原著(症例報告除く)
|
A multicenter prospective study to determine the optimal range of lymph node dissection in pancreatic cancer surgery after neoadjuvant chemotherapy (LYMRIN-Trial): Project study by the Japan Pancreas Society and JON 2302-P. 2025/06
|
|
19.
|
原著(症例報告除く)
|
Clinical importance of suspicious for malignancy compared to positive for malignancy in peritoneal cytology for surgically resected pancreatic cancer. 2025/06
|
|
20.
|
総説
|
Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in Asia. 2025/06
|
|
21.
|
原著(症例報告除く)
|
Impact of clinically diagnosed liver cirrhosis in patients with intrahepatic cholangiocarcinoma treated with systemic chemotherapy: a subgroup analysis of JCOG1113 2025/06
|
|
22.
|
原著(症例報告除く)
|
Three Molecular Developmental Pathways of Remnant Pancreatic Cancer after Resection: A Nationwide Project Study of Japan Pancreas Society 2025/06
|
|
23.
|
原著(症例報告除く)
|
A history of gastrectomy is a risk factor for choledocholithiasis in patients undergoing cholecystectomy: A single center retrospective study. 2025/05
|
|
24.
|
原著(症例報告除く)
|
The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study 2025/05
|
|
25.
|
その他
|
【肝腫瘍の外科治療戦略(肝細胞癌・肝内胆管癌・大腸癌肝転移以外)】転移性肝腫瘍 膵癌肝転移に対する外科的治療戦略 2025/05
|
|
26.
|
原著(症例報告除く)
|
膵切除術における外科的アプローチ別の収支損益分析 2025/05
|
|
27.
|
原著(症例報告除く)
|
Assessment of heterogeneity according to hospital or medical experience factors in outcomes of chemotherapy for advanced biliary tract cancer: a post-hoc analysis of JCOG1113 2025/04
|
|
28.
|
原著(症例報告除く)
|
NALIRIFOX in Japanese treatment-naïve patients with metastatic pancreatic adenocarcinoma: an open-label, phase II trial design 2025/04
|
|
29.
|
原著(症例報告除く)
|
Clinical role of intraperitoneal chemotherapy in patients with pancreatic ductal adenocarcinoma concomitant with occult peritoneal dissemination: A multicenter retrospective study 2025/03
|
|
30.
|
総説
|
Complexity and Experience Grading to Guide Patient Selection for Minimally-invasive Pancreatoduodenectomy: An ISGPS Consensus 2025/03
|
|
31.
|
その他
|
胆嚢腺扁平上皮癌10例の臨床病理学的検討 2025/03
|
|
32.
|
その他
|
Author's reply: Exploring the role of neoadjuvant therapy for resectable pancreatic cancer 2025/02
|
|
33.
|
原著(症例報告除く)
|
Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis 2025/02
|
|
34.
|
原著(症例報告除く)
|
Impact of pre-compression versus non-compression before parenchyma transection in left-sided pancreatic resection on the rate of clinically relevant pancreatic fistula: multicentre randomized clinical trial 2025/02
|
|
35.
|
原著(症例報告除く)
|
Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable/Borderline Resectable Pancreatic Ductal Adenocarcinoma 2025/01
|
|
36.
|
原著(症例報告除く)
|
Optimal duration of antimicrobial prophylaxis in patients undergoing distal pancreatectomy: A multicenter cohort study 2025/01
|
|
37.
|
原著(症例報告除く)
|
Optimal treatment strategy for patients with pancreatic cancer having positive peritoneal cytology: A nationwide multicenter retrospective cohort study supervised by the Japanese Society of Hepato-Biliary-Pancreatic Surgery 2025/01
|
|
38.
|
総説
|
膵癌に対するconversion surgeryの現状と将来展望 2025/01
|
|
39.
|
原著(症例報告除く)
|
膵原発のpure hepatoid carcinomaの1例 2024/12
|
|
40.
|
原著(症例報告除く)
|
Japanese classification of pancreatic carcinoma by the Japan Pancreas Society: Eighth edition 2024/11
|
|
41.
|
原著(症例報告除く)
|
Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021-22 2024/10
|
|
42.
|
原著(症例報告除く)
|
Preoperative CA19.9 level predicts lymph node metastasis in resectable adenocarcinoma of the head of the pancreas: A further plea for biological resectability criteria 2024/10
|
|
43.
|
原著(症例報告除く)
|
The efficacy of wrapping with polyglycolic acid mesh and fibrin glue in preventing clinically relevant pancreatic fistula after minimally invasive distal pancreatectomy (WRAP Study): study protocol for a multicenter randomized controlled trial in Japan 2024/10
|
|
44.
|
その他
|
【胆膵手術のちょっとしたコツ】膵癌術前審査腹腔鏡をどう行う?【動画付】 2024/10
|
|
45.
|
原著(症例報告除く)
|
Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or borderline resectable pancreatic ductal adenocarcinoma 2024/08
|
|
46.
|
原著(症例報告除く)
|
Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based chemotherapy followed by olaparib 2024/07
|
|
47.
|
原著(症例報告除く)
|
Factors affecting nonfunctioning small pancreatic neuroendocrine neoplasms and proposed new treatment strategies 2024/07
|
|
48.
|
その他
|
【肝胆膵癌に対する集学的治療の新潮流】膵癌 BR膵癌に対する集学的治療の展望 2024/07
|
|
49.
|
原著(症例報告除く)
|
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy 2024/06
|
|
50.
|
その他
|
【75歳以上高齢者胆膵疾患の病態と高齢者機能評価による治療戦略】高齢者膵癌患者における外科治療 2024/05
|
|
51.
|
原著(症例報告除く)
|
Is multidisciplinary treatment effective for invasive intraductal papillary mucinous carcinoma? 2024/03
|
|
52.
|
原著(症例報告除く)
|
Reconsideration of the clinical impact of neoadjuvant therapy in resectable and borderline resectable pancreatic cancer: A dual-institution collaborative clinical study 2024/03
|
|
53.
|
原著(症例報告除く)
|
Central pancreatectomy might be an acceptable surgical procedure for clinical T1 pancreatic body ductal adenocarcinoma: A multicenter retrospective analysis 2023/12
|
|
54.
|
原著(症例報告除く)
|
Development of a nomogram to predict survival in advanced biliary tract cancer 2023/12
|
|
55.
|
原著(症例報告除く)
|
Oncological role of surgical resection in patients with pancreatic ductal adenocarcinoma with liver-only synchronous metastases in a single-center retrospective study 2023/12
|
|
56.
|
原著(症例報告除く)
|
A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT) 2023/11
|
|
57.
|
原著(症例報告除く)
|
ASO Author Reflections: Characteristics of Surgery for Biliary Tract Cancer that Should be Considered During the Design of Future Clinical Trials 2023/11
|
|
58.
|
原著(症例報告除く)
|
Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries 2023/11
|
|
59.
|
原著(症例報告除く)
|
Randomized phase II trial of chemoradiotherapy with S-1 versus combination chemotherapy with gemcitabine and S-1 as neoadjuvant treatment for resectable pancreatic cancer (JASPAC 04) 2023/11
|
|
60.
|
原著(症例報告除く)
|
Impact of antithrombotic therapy on postpancreatectomy hemorrhage in 7116 patients: A project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery 2023/10
|
|
61.
|
その他
|
【膵癌取扱い規約第8版～変更の要点～】CYに関する変更点 2023/10
|
|
62.
|
原著(症例報告除く)
|
"Conversion surgery" for locally advanced pancreatic cancer: A position paper by the study group at the joint meeting of the International Association of Pancreatology (IAP) & Japan Pancreas Society (JPS) 2022 2023/09
|
|
63.
|
原著(症例報告除く)
|
Insights from managing clinical issues in distal pancreatectomy with en bloc coeliac axis resection: experiences from 626 patients 2023/09
|
|
64.
|
総説
|
Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? A position paper by experts in pancreatic surgery at the Joint Meeting of the International Association of Pancreatology (IAP) & the Japan Pancreas Society (JPS) 2022 in Kyoto 2023/09
|
|
65.
|
原著(症例報告除く)
|
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society 2023/08
|
|
66.
|
原著(症例報告除く)
|
Autophagy Inhibition Increased Sensitivity of Pancreatic Cancer Cells to Carbon Ion Radiotherapy 2023/07
|
|
67.
|
原著(症例報告除く)
|
Efficacy and safety of neoadjuvant nab-paclitaxel plus gemcitabine therapy in patients with borderline resectable pancreatic cancer: A multicenter single-arm phase II study (NAC-GA trial) 2023/07
|
|
68.
|
原著(症例報告除く)
|
Impact of neoadjuvant therapy on gut microbiome in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma 2023/06
|
|
69.
|
原著(症例報告除く)
|
膵癌リスク患者に対する定期的なサーベイランスに関する前向き研究 2023/06
|
|
70.
|
原著(症例報告除く)
|
A Retrospective Study Investigating the Safety and Efficacy of Nanoliposomal Irinotecan in Elderly Patients with Unresectable Pancreatic Cancer 2023/05
|
|
71.
|
その他
|
【外科手術と感染症】肝胆膵外科 膵頭十二指腸切除術における周術期感染症対策 2023/04
|
|
72.
|
その他
|
Academic value and impact of continuous global academic learning: the International HPB surgery journal club concept 2023/03
|
|
73.
|
原著(症例報告除く)
|
The academic impact and value of an international online surgery lecture series 2023/02
|
|
74.
|
総説
|
【膵癌Conversion Surgeryへの挑戦】遠隔転移膵癌に対するConversion Surgeryの現状と展望 2023/02
|
|
75.
|
原著(症例報告除く)
|
Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An international multicenter study 2023/01
|
|
76.
|
原著(症例報告除く)
|
Reevaluation of regional lymph nodes in patients with pancreatic ductal adenocarcinoma in the pancreatic body and tail 2023/01
|
|
77.
|
その他
|
【新・外科感染症診療ハンドブック】総論 COVID-19パンデミックと外科 国際共同研究の結果から 2022/12
|
|
78.
|
原著(症例報告除く)
|
Estimation of the degree of surgical difficulty anticipated for pancreatoduodenectomy: Preoperative and intraoperative factors 2022/11
|
|
79.
|
原著(症例報告除く)
|
Long-term outcomes of patients with multifocal intraductal papillary mucinous neoplasm following pancreatectomy 2022/11
|
|
80.
|
原著(症例報告除く)
|
Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study 2022/11
|
|
81.
|
原著(症例報告除く)
|
Risk factors and treatment strategy for clinical hepatico-jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy: A retrospective study 2022/11
|
|
82.
|
その他
|
【術前画像の読み解きガイド-的確な術式選択と解剖把握のために】膵臓 膵嚢胞性腫瘍(IPMN, MCN, SCN, SPN) 術式選択のポイント 2022/10
|
|
83.
|
原著(症例報告除く)
|
Clinical outcomes of organ-preserving pancreatectomy for benign or low-grade malignant pancreatic tumors: A multicenter nationwide survey in Japan 2022/08
|
|
84.
|
総説
|
Can trainees safely perform pancreatoenteric anastomosis? A systematic review, meta-analysis, and risk-adjusted analysis of postoperative pancreatic fistula 2022/07
|
|
85.
|
原著(症例報告除く)
|
New criteria of resectability for pancreatic cancer: A position paper by the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS) 2022/07
|
|
86.
|
その他
|
FOCUS クラウドファンディングで研究資金を集める! 臨床研究(先進医療制度を利用した特定研究)から得た経験 2022/06
|
|
87.
|
原著(症例報告除く)
|
High tumor budding predicts a poor prognosis in resected duodenal adenocarcinoma 2022/06
|
|
88.
|
原著(症例報告除く)
|
Synopsis of a clinical practice guideline for pancreatic ductal adenocarcinoma with peritoneal dissemination in Japan; Japan Peritoneal Malignancy Study Group 2022/06
|
|
89.
|
原著(症例報告除く)
|
Sporadic nonfunctional pancreatic neuroendocrine tumors: Risk of lymph node metastases and aggressiveness according to tumor size: A multicenter international study 2022/05
|
|
90.
|
総説
|
【肝胆膵癌におけるconversion therapy】膵癌におけるconversion therapy 膵01研究から得られた課題とconversion surgeryの現状 2022/05
|
|
91.
|
原著(症例報告除く)
|
Incidence and risk factors of nonalcoholic fatty liver disease after total pancreatectomy: A first multicenter prospective study in Japan 2022/04
|
|
92.
|
総説
|
External validation of postoperative pancreatic fistula prediction scores in pancreatoduodenectomy: a systematic review and meta-analysis 2022/03
|
|
93.
|
原著(症例報告除く)
|
Intraperitoneal Paclitaxel Treatment for Patients with Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination Provides a Survival Benefit 2022/03
|
|
94.
|
原著(症例報告除く)
|
術中過剰輸液は膵頭十二指腸切除後胃内容排出遅延の要因である 2022/03
|
|
95.
|
原著(症例報告除く)
|
胆嚢腫瘍を形成したBリンパ芽球性白血病の1例 2022/03
|
|
96.
|
原著(症例報告除く)
|
A simple risk score for detecting radiological occult metastasis in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma. 2022/02
|
|
97.
|
原著(症例報告除く)
|
Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study 2022/02
|
|
98.
|
原著(症例報告除く)
|
Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study) 2022/02
|
|
99.
|
原著(症例報告除く)
|
Validation of the triple-checked criteria for drain management after pancreatectomy. 2022/02
|
|
100.
|
原著(症例報告除く)
|
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. 2022/01
|
|
101.
|
その他
|
【conversion surgeryのすべて 切除不能を切除可能に!】切除不能膵癌に対するconversion surgery 2021/12
|
|
102.
|
その他
|
【Conversion surgeryアップデート】がん種別の最新動向 転移性膵癌に対するconversion surgery 2021/12
|
|
103.
|
原著(症例報告除く)
|
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 2021/11
|
|
104.
|
原著(症例報告除く)
|
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study. 2021/11
|
|
105.
|
その他
|
【胆と膵のスペシャリストが取るべき専門医/指導医とは?】膵癌登録について 登録の実際 2021/11
|
|
106.
|
その他
|
【膵・胆道癌における薬物療法のすべて】がん薬物療法のエビデンス 切除境界膵癌に対する術前治療 2021/11
|
|
107.
|
その他
|
【膵癌の診断と治療-最新の話題-】コンバージョン手術 2021/11
|
|
108.
|
その他
|
【Stepごとに要点解説 標準術式アトラス最新版】胆・膵 膵体尾部切除術±脾臓摘出術 2021/10
|
|
109.
|
原著(症例報告除く)
|
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 2021/09
|
|
110.
|
原著(症例報告除く)
|
Does direct invasion of peripancreatic lymph nodes impact survival in patients with pancreatic ductal adenocarcinoma? A retrospective dual-center study. 2021/08
|
|
111.
|
原著(症例報告除く)
|
Hepatic actinomycosis after total pancreatectomy: A case report 2021/08
|
|
112.
|
その他
|
Surgical Treatment of Pancreatic Ductal Adenocarcinoma 2021/08
|
|
113.
|
その他
|
【近年注目される膵臓疾患】切除不能膵がんにおけるconversion surgery 2021/08
|
|
114.
|
原著(症例報告除く)
|
Clinicopathological characteristics of pancreatic ductal adenocarcinoma with invasive micropapillary carcinoma component with emphasis on the usefulness of PKCζ immunostaining for detection of reverse polarity 2021/07
|
|
115.
|
原著(症例報告除く)
|
Diabetic control and nutritional status up to 1 year after total pancreatectomy: a nationwide multicentre prospective study 2021/07
|
|
116.
|
原著(症例報告除く)
|
Left-sided Portal Hypertension After Pancreaticoduodenectomy With Resection of the Portal Vein/Superior Mesenteric Vein Confluence in Patients With Pancreatic Cancer: A Project Study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. 2021/07
|
|
117.
|
その他
|
How to determine the surgical extent in patients with multifocal intraductal papillary mucinous neoplasm? 2021/06
|
|
118.
|
原著(症例報告除く)
|
Nutritional impact of active hexose-correlated compound for patients with resectable or borderline-resectable pancreatic cancer treated with neoadjuvant therapy 2021/06
|
|
119.
|
原著(症例報告除く)
|
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. 2021/06
|
|
120.
|
その他
|
【膵臓症候群(第3版)-その他の膵臓疾患を含めて-】膵腫瘍 膵癌 膵体尾部癌 2021/06
|
|
121.
|
原著(症例報告除く)
|
残膵癌に対する残膵全摘の治療成績 膵全摘術との比較検討 2021/06
|
|
122.
|
症例報告
|
嚢胞性腫瘍と鑑別が困難であった1型自己免疫性膵炎の1例 2021/06
|
|
123.
|
原著(症例報告除く)
|
Safety of Combined Division vs Separate Division of the Splenic Vein in Patients Undergoing Distal Pancreatectomy: A Noninferiority Randomized Clinical Trial 2021/05
|
|
124.
|
その他
|
【消化器癌;診断と治療のすべて】消化器癌の診断・病期分類・治療・成績 膵癌 集学的治療 切除不能膵癌に対する集学的治療 2021/05
|
|
125.
|
原著(症例報告除く)
|
Conversion surgery in patients with pancreatic cancer and peritoneal metastasis 2021/04
|
|
126.
|
その他
|
【これだけは知っておきたい胆膵疾患の診断・治療up-to-date】UR膵癌に対するConversion surgery 2021/04
|
|
127.
|
その他
|
化学療法群よりも生存期間４ヶ月延長 2021/03
|
|
128.
|
その他
|
【切除可能膵癌に対する標準治療:術前治療の意義】切除可能膵癌に対する術後補助治療 2021/02
|
|
129.
|
原著(症例報告除く)
|
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 2021/01
|
|
130.
|
原著(症例報告除く)
|
Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea-Japan Study 2021/01
|
|
131.
|
原著(症例報告除く)
|
Pancreatic trauma: proposal for management algorithm 2021
|
|
132.
|
原著(症例報告除く)
|
Follicular pancreatitisの臨床病理学的検討 2020/12
|
|
133.
|
原著(症例報告除く)
|
Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis 2020/12
|
|
134.
|
その他
|
【膵頭十二指腸切除の完全ガイド-定型術式から困難症例への対処法まで】膵頭十二指腸切除の定型術式 PDの定型術式・ポイント解説 胆管空腸吻合は連続縫合か結節縫合か 2020/12
|
|
135.
|
原著(症例報告除く)
|
Delaying surgery for patients with a previous SARS-CoV-2 infection 2020/11
|
|
136.
|
原著(症例報告除く)
|
Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic 2020/11
|
|
137.
|
原著(症例報告除く)
|
Risk prediction for malignant intraductal papillary mucinous neoplasm of the pancreas: logistic regression versus machine learning 2020/11
|
|
138.
|
原著(症例報告除く)
|
Impact of Antithrombotic Agents on Postpancreatectomy Hemorrhage: Results from a Retrospective Multicenter Study 2020/10
|
|
139.
|
原著(症例報告除く)
|
Multicenter randomized phase II trial of prophylactic right-half dissection of superior mesenteric artery nerve plexus in pancreatoduodenectomy for pancreatic head cancer 2020/09
|
|
140.
|
原著(症例報告除く)
|
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations 2020/07
|
|
141.
|
原著(症例報告除く)
|
Octogenarians With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study. 2020/07
|
|
142.
|
原著(症例報告除く)
|
Optimal Treatment for Octogenarians With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study 2020/07
|
|
143.
|
原著(症例報告除く)
|
Propensity score-matched analysis of internal stent vs external stent for pancreatojejunostomy during pancreaticoduodenectomy: Japanese-Korean cooperative project 2020/07
|
|
144.
|
原著(症例報告除く)
|
Risk factors for pancreatic fistula grade C after pancreatoduodenectomy: A large prospective, multicenter Japan-Taiwan collaboration study 2020/07
|
|
145.
|
その他
|
【胆膵疾患における栄養サポート】膵頭十二指腸切除術後の栄養管理(脂肪肝対策) 2020/07
|
|
146.
|
原著(症例報告除く)
|
Role of phosphorylated Smad3 signal components in intraductal papillary mucinous neoplasm of pancreas 2020/06
|
|
147.
|
その他
|
【膵癌診療ガイドライン改訂を外科医はこう読み解く-ディベート&ディスカッション】大動脈周囲リンパ節のサンプリングが陽性だった 切除を行うvs行わない ディベート 切除を行うの立場から 2020/06
|
|
148.
|
原著(症例報告除く)
|
Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma 2020/05
|
|
149.
|
原著(症例報告除く)
|
Global Survey on Pancreatic Surgery During the COVID-19 Pandemic 2020/05
|
|
150.
|
総説
|
The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma 2020/04
|
|
151.
|
原著(症例報告除く)
|
Bile Duct Stones Predict a Requirement for Cholecystectomy in Older Patients. 2020/03
|
|
152.
|
その他
|
リトアニア外科学講演・ヴィリニュス大学視察報告 2020/03
|
|
153.
|
原著(症例報告除く)
|
Role of phosphorylated Smad3 signal components in intraductal papillary mucinous neoplasm of pancreas. 2020/01
|
|
154.
|
原著(症例報告除く)
|
Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: A nationwide, cancer registry-based study from the Japan Pancreas Society. 2019/12
|
|
155.
|
その他
|
【膵癌治療の進歩】予後改善を目指した膵癌治療戦略 2019/12
|
|
156.
|
その他
|
【外科医とがん登録-NCDから見えてきたわが国のがん治療の実態-】膵がん登録 2019/11
|
|
157.
|
その他
|
【術前治療時代の膵癌診断・治療戦略】術前治療後外科切除術の留意点 2019/11
|
|
158.
|
総説
|
Surgical indication for and desirable outcomes of conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma 2019/10
|
|
159.
|
その他
|
【すぐに使える周術期管理マニュアル】術式別の術前・術中・術後管理 膵 膵頭十二指腸切除術 2019/10
|
|
160.
|
原著(症例報告除く)
|
Assessment of clinical outcome of cholecystectomy according to age in preparation for the "Silver Tsunami". 2019/09
|
|
161.
|
原著(症例報告除く)
|
Clinical impact of the sequentially-checked drain removal criteria on postoperative outcomes after pancreatectomy: a retrospective study. 2019/09
|
|
162.
|
原著(症例報告除く)
|
The efficacy of polyglycolic acid felt reinforcement in preventing postoperative pancreatic fistula after pancreaticojejunostomy in patients with main pancreatic duct less than 3 mm in diameter and soft pancreas undergoing pancreatoduodenectomy (PLANET-PJ trial): study protocol for a multicentre randomized phase III trial in Japan and Korea. 2019/08
|
|
163.
|
その他
|
【膵切除後の合併症とその対策】膵切除後の出血性合併症 2019/08
|
|
164.
|
原著(症例報告除く)
|
Surgical treatment of metastatic pancreatic ductal adenocarcinoma: A review of current literature. 2019/07
|
|
165.
|
その他
|
【膵手術・膵癌治療の進歩】局所進行切除不能膵癌に対する集学的治療とconversion surgery 2019/07
|
|
166.
|
原著(症例報告除く)
|
Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery. 2019/06
|
|
167.
|
原著(症例報告除く)
|
Phase II Study of the Triple Combination Chemotherapy of SOXIRI (S-1/Oxaliplatin/Irinotecan) in Patients with Unresectable Pancreatic Ductal Adenocarcinoma. 2019/06
|
|
168.
|
その他
|
【腹膜炎・腹水に対する診療の進歩】悪性腫瘍に伴う腹膜炎・腹水の診療 膵癌による癌性腹膜炎 2019/06
|
|
169.
|
その他
|
The effect of neoadjuvant chemotherapy with gemcitabine and S-1 for resectable pancreatic cancer (randomized phase II/III trial; Prep-02/JSAP-05). 2019/05
|
|
170.
|
原著(症例報告除く)
|
A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy. 2019/04
|
|
171.
|
原著(症例報告除く)
|
Adipophilin expression is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinoma: An immunohistochemical analysis. 2019/04
|
|
172.
|
原著(症例報告除く)
|
Clinicopathological and immunological features of follicular pancreatitis-a distinct disease entity characterized by Th17 activation. 2019/04
|
|
173.
|
症例報告
|
Prognosis in Patients With Gallbladder Edema Misdiagnosed as Cholecystitis. 2019/04
|
|
174.
|
その他
|
【6つの臓器に会いにいこう!すべての消化器外科・内科ナースのためのケアに役立つ解剖生理】 消化器の解剖生理をめぐる旅 胆道 2019/04
|
|
175.
|
原著(症例報告除く)
|
Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients. 2019/03
|
|
176.
|
その他
|
膵神経内分泌腫瘍の外科的治療適応とその手術方法に関して 可能であれば原発巣・転移巣ともに切除することが勧められる 2019/03
|
|
177.
|
原著(症例報告除く)
|
A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study. 2019/02
|
|
178.
|
原著(症例報告除く)
|
Evaluation of relative criteria for single-incision laparoscopic cholecystectomy. 2019/02
|
|
179.
|
その他
|
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP-05). 2019/02
|
|
180.
|
原著(症例報告除く)
|
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05). 2019/02
|
|
181.
|
その他
|
Results of conversion surgery after the triple combination chemotherapy of SOXIRI (S-1/oxaliplatin/irinotecan) in patients with unresectable pancreatic cancer. 2019/02
|
|
182.
|
原著(症例報告除く)
|
Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic Recurrence in Patients with Curatively Resected Pancreatic Adenocarcinoma. 2019/02
|
|
183.
|
症例報告
|
腹膜転移を有する膵尾部癌に対してS-1＋paclitaxel経静脈・腹腔内投与併用療法後にconversion surgeryを施行し長期無再発生存が得られた1例 2019/02
|
|
184.
|
その他
|
膵癌に対する外科的治療の今後の位置づけは? 低侵襲手術と拡大手術の二極化が進行すると考えられる(Q&A) 2019/02
|
|
185.
|
原著(症例報告除く)
|
Does modified Blumgart anastomosis without intra-pancreatic ductal stenting reduce post-operative pancreatic fistula after pancreaticojejunostomy? 2019/01
|
|
186.
|
原著(症例報告除く)
|
Preoperative weight loss program involving a 20-day very low-calorie diet for obesity before laparoscopic gastrectomy for gastric cancer. 2019/01
|
|
187.
|
その他
|
医の最前線より：クラウドファンディングで研究資金を調達 2019
|
|
188.
|
原著(症例報告除く)
|
1型自己免疫性膵炎(LPSP)と2型自己免疫性膵炎(IDCP)の好中球浸潤の比較 2018/12
|
|
189.
|
総説
|
Conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma: where do we stand in 2018? 2018/12
|
|
190.
|
原著(症例報告除く)
|
MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma. 2018/11
|
|
191.
|
症例報告
|
Near-miss hepatic duct injury resulting from misidentification of Calot's triangle during laparoscopic cholecystectomy 2018/11
|
|
192.
|
その他
|
【DP(尾側膵切除術)を極める!】 尾側膵切除術における膵断端処理法 2018/11
|
|
193.
|
原著(症例報告除く)
|
Dual-center randomized clinical trial exploring the optimal duration of antimicrobial prophylaxis in patients undergoing pancreaticoduodenectomy following biliary drainage. 2018/09
|
|
194.
|
原著(症例報告除く)
|
Use of a piece of free omentum to prevent bile leakage after subtotal cholecystectomy. 2018/09
|
|
195.
|
その他
|
【切除可能膵癌の術前・術中・術後】 切除可能膵癌に対する手術中の留意点 2018/09
|
|
196.
|
症例報告
|
Cytological features of hepatoid adenocarcinoma of the gallbladder: A case report with immunocytochemical analyzes. 2018/08
|
|
197.
|
その他
|
【術後胆道感染症】 膵頭十二指腸切除術における術前胆道ドレナージ・胆管炎合併と術後膵液瘻の関連 2018/08
|
|
198.
|
総説
|
【膵炎の基礎研究・病態解明】 1型自己免疫性膵炎における好塩基球の関与 2018/08
|
|
199.
|
原著(症例報告除く)
|
特集 腹膜播種治療の今 膵癌腹膜転移の診断と治療 2018/08
|
|
200.
|
原著(症例報告除く)
|
Splenic vein resection together with the pancreatic parenchyma versus separated resection after isolation of the parenchyma during distal pancreatectomy (COSMOS-DP trial): study protocol for a randomised controlled trial. 2018/07
|
|
201.
|
原著(症例報告除く)
|
Surgical management of intraductal papillary mucinous neoplasm with main duct involvement: an international expert survey and case-vignette study. 2018/07
|
|
202.
|
その他
|
【"はじめてさん"でも3ステップで安心!消化器外科"マスト"8術式完全ガイド】 肝胆膵 膵頭十二指腸切除術 2018/07
|
|
203.
|
原著(症例報告除く)
|
Cytological features of mixed adenoneuroendocrine carcinoma of the ampulla of Vater: A case report with immunocytochemical analyses. 2018/06
|
|
204.
|
その他
|
【こうやって教える・学ぶ 高難度消化器外科手術-新エキスパートへの登竜門】肝胆膵 Soft pancreasに対する開腹膵頭十二指腸切除術 2018/06
|
|
205.
|
その他
|
【膵疾患の診断と治療-21世紀の進歩とUp-to-date】 Key words 膵癌のconversion surgery 2018/06
|
|
206.
|
原著(症例報告除く)
|
A randomized controlled trial of running versus interrupted subcuticular sutures for skin closure in open gastric surgery 2018/05
|
|
207.
|
総説
|
European evidence-based guidelines on pancreatic cystic neoplasms 2018/05
|
|
208.
|
原著(症例報告除く)
|
Evaluation of relative criteria for single-incision laparoscopic cholecystectomy. 2018/05
|
|
209.
|
その他
|
【膵癌update】 トピックス 腹膜播種の化学療法 腹膜転移膵癌の化学療法 2018/05
|
|
210.
|
その他
|
【膵癌に挑む】 膵切除後膵液瘻の予防と対策 2018/05
|
|
211.
|
原著(症例報告除く)
|
Borderline resectable膵癌の定義と治療方針 2018/04
|
|
212.
|
その他
|
Correction to: Basophils activated via TLR signaling may contribute to pathophysiology of type 1 autoimmune pancreatitis 2018/04
|
|
213.
|
原著(症例報告除く)
|
A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1202). 2018/03
|
|
214.
|
原著(症例報告除く)
|
Basophils activated via TLR signaling may contribute to pathophysiology of type 1 autoimmune pancreatitis. 2018/03
|
|
215.
|
原著(症例報告除く)
|
Clinical impact of developing better practices at the institutional level on surgical outcomes after distal pancreatectomy in 1515 patients: Domestic audit of the Japanese Society of Pancreatic Surgery. 2018/03
|
|
216.
|
総説
|
Reappraisal of previously reported meta-analyses on antibiotic prophylaxis for low-risk laparoscopic cholecystectomy: an overview of systematic reviews. 2018/03
|
|
217.
|
原著(症例報告除く)
|
Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic ductal adenocarcinoma? -Multicenter surgical group study. 2018/01
|
|
218.
|
その他
|
【進行消化器癌のconversion surgery】 膵臓癌 切除不能膵癌 2018/01
|
|
219.
|
その他
|
〔特集〕BRとUR膵癌の最近のトピックス 特集にあたって 2018
|
|
220.
|
原著(症例報告除く)
|
Proposed Nomogram Predicting the Individual Risk of Malignancy in the Patients With Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas 2017/12
|
|
221.
|
原著(症例報告除く)
|
Reinforced staplers for distal pancreatectomy. 2017/12
|
|
222.
|
原著(症例報告除く)
|
Retrospective Study of the Correlation Between Pathological Tumor Size and Survival After Curative Resection of T3 Pancreatic Adenocarcinoma: Proposal for Reclassification of the Tumor Extending Beyond the Pancreas Based on Tumor Size 2017/11
|
|
223.
|
原著(症例報告除く)
|
特集 局所進行膵癌の治療限界に挑む 局所進行切除不能膵癌のconversion surgeryへのタイミング 2017/11
|
|
224.
|
その他
|
【どでかぃ図解でカンタンスイスイはやわかり 肝胆膵の治療とケアQ&A】 (Chapter4)膵臓の治療とケア はやわかり 膵臓の治療と治療後の観察ポイント 化学療法 膵がんの化学療法ではどんな薬が使われるの?治療中の注意点は? 2017/10
|
|
225.
|
その他
|
【どでかぃ図解でカンタンスイスイはやわかり 肝胆膵の治療とケアQ&A】 (Chapter4)膵臓の治療とケア はやわかり 膵臓の治療と治療後の観察ポイント 膵管ドレナージ(ENPD、EPS) 膵管ドレナージ(ENPD、EPS)ってどんな治療? 2017/10
|
|
226.
|
その他
|
【どでかぃ図解でカンタンスイスイはやわかり 肝胆膵の治療とケアQ&A】 (Chapter4)膵臓の治療とケア はやわかり 膵臓の治療と治療後の観察ポイント 膵管ドレナージ(ENPD、EPS) 膵管ドレナージ(ENPD、EPS)の合併症にはどのようなものがあるの?早期発見のための観察ポイント・対応は? 2017/10
|
|
227.
|
その他
|
【どでかぃ図解でカンタンスイスイはやわかり 肝胆膵の治療とケアQ&A】 (Chapter4)膵臓の治療とケア はやわかり 膵臓の治療と治療後の観察ポイント 膵全摘術 膵全摘術ってどんな治療? 2017/10
|
|
228.
|
その他
|
【どでかぃ図解でカンタンスイスイはやわかり 肝胆膵の治療とケアQ&A】 (Chapter4)膵臓の治療とケア はやわかり 膵臓の治療と治療後の観察ポイント 膵全摘術 膵全摘術の合併症にはどのようなものがあるの? 2017/10
|
|
229.
|
その他
|
【どでかぃ図解でカンタンスイスイはやわかり 肝胆膵の治療とケアQ&A】 (Chapter4)膵臓の治療とケア はやわかり 膵臓の治療と治療後の観察ポイント 膵全摘術 膵全摘術後のケアと退院指導はどのように行うの? 2017/10
|
|
230.
|
その他
|
【どでかぃ図解でカンタンスイスイはやわかり 肝胆膵の治療とケアQ&A】 (Chapter4)膵臓の治療とケア はやわかり 膵臓の治療と治療後の観察ポイント 膵全摘術 膵全摘術後の観察ポイントと発見時の対応は? 2017/10
|
|
231.
|
その他
|
【どでかぃ図解でカンタンスイスイはやわかり 肝胆膵の治療とケアQ&A】 (Chapter4)膵臓の治療とケア はやわかり 膵臓の治療と治療後の観察ポイント 膵中央切除術 膵中央切除術ってどんな治療? 2017/10
|
|
232.
|
その他
|
【どでかぃ図解でカンタンスイスイはやわかり 肝胆膵の治療とケアQ&A】 (Chapter4)膵臓の治療とケア はやわかり 膵臓の治療と治療後の観察ポイント 膵中央切除術 膵中央切除術の合併症にはどのようなものがあるの? 2017/10
|
|
233.
|
その他
|
【どでかぃ図解でカンタンスイスイはやわかり 肝胆膵の治療とケアQ&A】 (Chapter4)膵臓の治療とケア はやわかり 膵臓の治療と治療後の観察ポイント 膵中央切除術 膵中央切除術の合併症を早期に発見するための観察ポイント・対応は? 2017/10
|
|
234.
|
その他
|
【どでかぃ図解でカンタンスイスイはやわかり 肝胆膵の治療とケアQ&A】 (Chapter4)膵臓の治療とケア はやわかり 膵臓の治療と治療後の観察ポイント 膵中央切除術 膵中央切除術後のケアと退院指導はどのように行うの? 2017/10
|
|
235.
|
その他
|
【消化器癌腹膜播種の最新知見】 膵癌における腹腔内化学療法 2017/10
|
|
236.
|
その他
|
【急性腹症に対する低侵襲アプローチ-適応と手技】 急性胆嚢炎 2017/09
|
|
237.
|
その他
|
【あなたはどこまで理解している?外科医が広げる消化管・肝胆膵の地図】 肝・胆・膵 2017/08
|
|
238.
|
原著(症例報告除く)
|
Developing better practices at the institutional level leads to better outcomes after pancreaticoduodenectomy in 3,378 patients: domestic audit of the Japanese Society of Pancreatic Surgery. 2017/07
|
|
239.
|
原著(症例報告除く)
|
Clinical effect of pancreaticojejunostomy with a long-internal stent during pancreaticoduodenectomy in patients with a main pancreatic duct of small diameter 2017/06
|
|
240.
|
原著(症例報告除く)
|
Morphological and immunohistochemical comparison of intrapancreatic nerves between chronic pancreatitis and type 1 autoimmune pancreatitis 2017/06
|
|
241.
|
原著(症例報告除く)
|
Comparison of surgical outcomes of three different stump closure techniques during distal pancreatectomy 2017/05
|
|
242.
|
原著(症例報告除く)
|
Optimal Duration of Prophylactic Antibiotics Administration in Pancreaticoduodenectomy Surgery 2017/05
|
|
243.
|
原著(症例報告除く)
|
Survival benefit of intravenous and intraperitoneal paclitaxel with S-1 in pancreatic ductal adenocarcinoma patients with peritoneal metastasis: a retrospective study in a single institution 2017/05
|
|
244.
|
その他
|
腹膜転移膵癌に対する新規治療法とconversion surgeryの役割 2017/05
|
|
245.
|
原著(症例報告除く)
|
Randomized clinical trial of duct-to-mucosa pancreaticogastrostomy versus handsewn closure after distal pancreatectomy. 2017/04
|
|
246.
|
その他
|
Commentary on: Prevention of postoperative bile leakage using an omental plugging technique for subtotal cholecystectomy in the "difficult gallbladder" 2017/02
|
|
247.
|
原著(症例報告除く)
|
Multicenter phase II study of intravenous and intraperitoneal paclitaxel with S-1 for pancreatic ductal adenocarcinoma patients with peritoneal metastasis 2017/02
|
|
248.
|
原著(症例報告除く)
|
Clinical benefits of neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreatic head: an observational study using inverse probability of treatment weighting. 2017/01
|
|
249.
|
原著(症例報告除く)
|
Clinical outcomes of pancreatic ductal adenocarcinoma resection following neoadjuvant chemoradiation therapy vs. chemotherapy 2017/01
|
|
250.
|
原著(症例報告除く)
|
Acute median arcuate ligament syndrome after pancreaticoduodenectomy 2016/12
|
|
251.
|
原著(症例報告除く)
|
Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma 2016/12
|
|
252.
|
その他
|
特集 膵癌取扱い規約第7版の解説と主な変更点 特集にあたって 2016/12
|
|
253.
|
原著(症例報告除く)
|
Clinicopathological Characteristics of Young Patients With Pancreatic Cancer: An Analysis of Data From Pancreatic Cancer Registry of Japan Pancreas Society 2016/11
|
|
254.
|
原著(症例報告除く)
|
Impact of treatment duration of neoadjuvant FIRINOX in patients with borderline resectable pancreatic cancer: a pilot trial 2016/10
|
|
255.
|
原著(症例報告除く)
|
Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites 2016/10
|
|
256.
|
原著(症例報告除く)
|
Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma 2016/09
|
|
257.
|
原著(症例報告除く)
|
Grade B pancreatic fistulas do not affect survival after pancreatectomy for pancreatic cancer: A multicenter observational study 2016/08
|
|
258.
|
原著(症例報告除く)
|
Reappraisal of total pancreatectomy in 45 patients with pancreatic ductal adenocarcinoma in the modern era using matched-pairs analysis: multicenter study group of pancreatobiliary surgery in Japan 2016/08
|
|
259.
|
原著(症例報告除く)
|
Staple-Line Reinforcement of the Duodenal Stump With Intracorporeal Lembert's Sutures in Laparoscopic Distal Gastrectomy With Roux-en-Y Reconstruction for Gastric Cancer 2016/08
|
|
260.
|
原著(症例報告除く)
|
Safety of laparoscopic cholecystectomy after coronary artery bypass with the right gastroepiploic artery 2016/07
|
|
261.
|
原著(症例報告除く)
|
Evaluation of the efficacy of daikenchuto (TJ -100) for the prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, double-blind, randomized, placebo-controlled trial 2016/05
|
|
262.
|
原著(症例報告除く)
|
Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial 2016/03
|
|
263.
|
原著(症例報告除く)
|
Prognosis after surgical treatment for pancreatic cancer in patients aged 80 years or older: a multicenter study 2016/03
|
|
264.
|
その他
|
【イラストでみる最新の胆・膵消化管吻合術】 膵体尾部切除術における膵断端処理 膵尾側断端膵管胃粘膜吻合法の実際と治療成績 2016/03
|
|
265.
|
原著(症例報告除く)
|
Alleviating effect of active hexose correlated compound (AHCC) on chemotherapy-related adverse events in patients with unresectable pancreatic ductal adenocarcinoma 2016/02
|
|
266.
|
その他
|
【胆道癌・膵癌に対する化学療法の最前線】 膵癌 腹膜転移を有する膵癌に対する化学療法 2016/02
|
|
267.
|
総説
|
潜在性腹膜転移膵癌治療におけるconversion surgeryの役割 2016/02
|
|
268.
|
原著(症例報告除く)
|
A clinical role of staging laparoscopy in patients with radiographically defined locally advanced pancreatic ductal adenocarcinoma 2016/01
|
|
269.
|
原著(症例報告除く)
|
Phase I study assessing the feasibility of the triple combination chemotherapy of SOXIRI (S-1/oxaliplatin/irinotecan) in patients with unresectable pancreatic ductal adenocarcinoma 2016/01
|
|
270.
|
その他
|
Impact of preoperative biliary drainage on long-term survival in resected pancreatic ductal adenocarcinoma: A multicenter observational study 2015/12
|
|
271.
|
その他
|
Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study 2015/12
|
|
272.
|
その他
|
Postoperative infectious complications after pancreatic resection 2015/11
|
|
273.
|
その他
|
Successful multidisciplinary therapy for small cell carcinomas arising from the extrahepatic bile duct 2015/11
|
|
274.
|
その他
|
Multicenter comparative study of laparoscopic and open distal pancreatectomy using propensity score-matching 2015/10
|
|
275.
|
その他
|
Simple suturing technique for umbilical dimple wound after single-incision laparoscopic surgery 2015/10
|
|
276.
|
その他
|
National comprehensive cancer network resectability status for pancreatic carcinoma predicts overall survival 2015/09
|
|
277.
|
症例報告
|
Pylorus-preserving total pancreatectomy for metastatic renal cell carcinoma: a case report 2015/09
|
|
278.
|
その他
|
Central pancreatectomy with double pancreaticojejunostomy 2015/08
|
|
279.
|
その他
|
【新 膵癌治療-アブラキサン・FOLFIRINOXをどう使うか】切除不能進行膵癌の化学療法 潜在性腹膜転移を有する膵癌患者に対するS-1+パクリタキセル経静脈・腹腔内併用療法 2015/07
|
|
280.
|
その他
|
Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma 2015/06
|
|
281.
|
その他
|
Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients 2015/06
|
|
282.
|
原著(症例報告除く)
|
Comparison of neutrophil infiltration between type 1 and type 2 autoimmune pancreatitis 2015/05
|
|
283.
|
症例報告
|
Granulocyte-colony stimulating factor producing anaplastic carcinoma of the pancreas treated by distal pancreatectomy and chemotherapy: report of a case 2015/05
|
|
284.
|
その他
|
Potential role of surgical resection for pancreatic cancer in the very elderly 2015/05
|
|
285.
|
症例報告
|
高度の低アルブミン血症を伴ったIntraductal Papillary Mucinous Carcinomaに対し膵頭十二指腸切除術を行った1例 2015/04
|
|
286.
|
その他
|
期待される最新研究 腹膜転移を有する膵癌に対するS-1+PTX経静脈・腹腔内併用療法の研究 2015/03
|
|
287.
|
その他
|
Reappraisal of peritoneal washing cytology in 984 patients with pancreatic ductal adenocarcinoma who underwent margin-negative resection 2015/01
|
|
288.
|
その他
|
海外文献紹介 Scoring System to Predict Pancreatic Fistula After Pancreaticoduodenectomy: A UK Multicenter Study 膵頭十二指腸切除後膵瘻発生を予測するためのスコアリングシステム 2015
|
|
289.
|
症例報告
|
膵癌におけるIgG4陽性細胞について 2014/12
|
|
290.
|
総説
|
膵癌におけるＩｇＧ４陽性細胞について 2014/12
|
|
291.
|
症例報告
|
Improved survival with combined gemcitabine and S-1 for locally advanced pancreatic cancer: pooled analysis of three randomized studies 2014/10
|
|
292.
|
その他
|
術中・術後合併症とその管理 感染系・その他 腹腔内膿瘍 2014/10
|
|
293.
|
症例報告
|
Antibiotic prophylaxis in laparoscopic cholecystectomy: a randomized controlled trial 2014/09
|
|
294.
|
症例報告
|
Role of adjuvant surgery in initially unresectable pancreatic cancer after long-term chemotherapy or chemoradiation therapy: survival benefit? 2014/09
|
|
295.
|
症例報告
|
Antitumor effect of angiotensin II type 1 receptor blocker losartan for orthotopic rat pancreatic adenocarcinoma 2014/08
|
|
296.
|
原著(症例報告除く)
|
Comparison of Tc-99m GSA scintigraphy and CT volumetry for evaluation in portal vein embolization 2014/08
|
|
297.
|
その他
|
第45回日本膵臓学会大会「膵癌診療ガイドライン」に臨床現場から提言 2014/08
|
|
298.
|
症例報告
|
膵癌の集学的治療 切除可能から切除不能まで 2014/08
|
|
299.
|
その他
|
膵頭十二指腸切除術後の脂肪肝に対するパンクレリパーゼ製剤の治療効果 2014/08
|
|
300.
|
症例報告
|
Pancreaticogastrostomy following distal pancreatectomy prevents pancreatic fistula-related complications 2014/07
|
|
301.
|
原著(症例報告除く)
|
Possible involvement of Toll like receptor7 in the development of type 1 autoimmune pancreatitis 2014/07
|
|
302.
|
症例報告
|
Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy. 2014/03
|
|
303.
|
症例報告
|
Influence of preoperative anti-cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: Project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. 2014/02
|
|
304.
|
症例報告
|
Clinical impact of preoperative cholangitis after biliary drainage in patients who undergo pancreaticoduodenectomy on postoperative pancreatic fistula. 2014/01
|
|
305.
|
症例報告
|
Less morbidity after introduction of a new departmental policy for patients who undergo open distal pancreatectomy. 2014/01
|
|
306.
|
症例報告
|
Phase II clinical study of alternate-day oral therapy with S-1 as first-line chemotherapy for locally advanced and metastatic pancreatic cancer. 2014/01
|
|
307.
|
その他
|
切除不能膵癌における治療奏効例の手術適応とその成績 2014/01
|
|
308.
|
その他
|
Laparoscopic distal pancreatectomy for a pancreatic lymphoepithelial cyst: case report and review of literature. 2013/11
|
|
309.
|
その他
|
当科における膵頭十二指腸切除術後の静脈血栓症予防および合併症低減策 2013/11
|
|
310.
|
その他
|
Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery 2013/08
|
|
311.
|
原著(症例報告除く)
|
The similarity of Type 1 autoimmune pancreatitis to pancreatic ductal adenocarcinoma with significant IgG4-positive plasma cell infiltration. 2013/06
|
|
312.
|
その他
|
Proposal for splenectomy-omitting radical distal pancreatectomy in well-selected left-sided pancreatic cancer: multicenter survey study. 2013/03
|
|
313.
|
その他
|
The clinical role of critical pathway implementation for pancreaticoduodenectomy in 179 patients. 2013/03
|
|
314.
|
その他
|
Activation of alpha-smooth muscle actin-positive myofibroblast-like cells after chemotherapy with gemcitabine in a rat orthotopic pancreatic cancer model. 2013/02
|
|
315.
|
その他
|
急性膵炎に由来した無症候性脾内膵仮性嚢胞の1例 脾内膵仮性嚢胞本邦報告例の検討 2013/02
|
|
316.
|
その他
|
Absence of cystic duct leakage using locking clips in 1017 cases of laparoscopic cholecystectomy. 2012/11
|
|
317.
|
その他
|
胆・肝・膵・脾の手術 膵頭十二指腸切除術 2012/11
|
|
318.
|
その他
|
Ultrasonic Scalpel for Gastric Cancer Surgery: a Prospective Randomized Study. 2012/10
|
|
319.
|
症例報告
|
出血性合併症を繰り返した重症急性膵炎の1例 2012/10
|
|
320.
|
その他
|
膵頭十二指腸切除術クリニカルパスによる周術期管理の変遷 2012/09
|
|
321.
|
原著(症例報告除く)
|
肝胆膵のチューブ管理を極める!異常の緊急度がわかる・異常発見時の対応がわかる モリソン窩ドレーン 2012/07
|
|
322.
|
症例報告
|
Autoimmune pancreatitis with histologically proven lymphoplasmacytic sclerosing pancreatitis with granulocytic epithelial lesions. 2012/04
|
|
323.
|
その他
|
Circulating CD4+CD25+ Regulatory T Cells in Patients With Pancreatic Cancer. 2012/04
|
|
324.
|
その他
|
Circulating Myeloid Dendritic Cells as Prognostic Factors in Patients with Pancreatic Cancer Who Have Undergone Surgical Resection. 2012/04
|
|
325.
|
原著(症例報告除く)
|
Neo-adjuvant Chemoradiation Therapy Using S-1 Followed by Surgical Resection in Patients with Pancreatic Cancer. 2012/04
|
|
326.
|
その他
|
Long-term results of surgical resection after preoperative chemoradiation in patients with pancreatic cancer. 2012/03
|
|
327.
|
その他
|
The role of circulating dendritic cells in patients with unresectable pancreatic cancer. 2011/11
|
|
328.
|
その他
|
ゲムシタビン単独療法が奏効した肝門部胆管がんの1例 2011/11
|
|
329.
|
原著(症例報告除く)
|
肝胆膵 膵癌におけるstaging laparoscopyの手技 2011/11
|
|
330.
|
その他
|
Involvement of Inducible Costimulator- and Interleukin 10-Positive Regulatory T Cells in the Development of IgG4-Related Autoimmune Pancreatitis. 2011/10
|
|
331.
|
その他
|
膵癌に対する術前術後補助療法の現状と今後の展望 2011/10
|
|
332.
|
原著(症例報告除く)
|
誌上ディベート 切除可能膵癌に有効な補助療法とは 術前補助化学放射線療法の立場から 2011/09
|
|
333.
|
原著(症例報告除く)
|
Borderline Resectable膵癌をめぐって 膵癌切除患者における術前化学放射線療法と長期成績 2011/07
|
|
334.
|
原著(症例報告除く)
|
Predictive risk factors for clinically relevant pancreatic fistula analyzed in 1,239 patients with pancreaticoduodenectomy: multicenter data collection as a project study of pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. 2011/07
|
|
335.
|
原著(症例報告除く)
|
Use of the new ultrasonically curved shear in pancreaticoduodenectomy for periampullary cancer. 2011/07
|
|
336.
|
原著(症例報告除く)
|
胆道・膵疾患の画像診断 膵疾患 膵癌 画像診断とその問題点 2011/07
|
|
337.
|
その他
|
Selective Use of Staging Laparoscopy Based on Carbohydrate Antigen 19-9 Level and Tumor Size in Patients With Radiographically Defined Potentially or Borderline Resectable Pancreatic Cancer. 2011/04
|
|
338.
|
その他
|
Discussion at the plenary session of the 22nd Congress of the Japanese Society of Hepato-Biliary-Pancreatic Surgery, 2011/03
|
|
339.
|
その他
|
Discussion at the plenary session of the 22nd Congress of the Japanese Society of Hepato-Biliary-Pancreatic Surgery, 27 May 2010 2011/03
|
|
340.
|
原著(症例報告除く)
|
地域連携パスを使った地域医療の質向上 胆膵癌のクリニカルパスｰ院内から院外へｰ 2011/03
|
|
341.
|
原著(症例報告除く)
|
Reinforcement of pancreticojejunostomy using polyglycolic acid mesh and fibrin glue sealant. 2011/01
|
|
342.
|
症例報告
|
Idiopathic Duct-Centric Pancreatitis (IDCP) with Immunological Studies. 2010/12
|
|
343.
|
その他
|
当科における膵頭十二指腸切除術の手技と工夫 2010/12
|
|
344.
|
原著(症例報告除く)
|
膵癌に対する術前化学放射線療法後切除例の長期予後の検討 2010/11
|
|
345.
|
原著(症例報告除く)
|
A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patients. 2010/09
|
|
346.
|
原著(症例報告除く)
|
胆膵診療に必須な細胞診･生検診断の知識 膵癌に対する腹腔鏡下細胞診と生検の意義 2010/09
|
|
347.
|
原著(症例報告除く)
|
Is a Nonstented Duct-to-Mucosa Anastomosis Using the Modified Kakita Method a Safe Procedure? 2010/03
|
|
348.
|
原著(症例報告除く)
|
膵管癌に対する術前放射線化学療法後外科的治療成績 2009/10
|
|
349.
|
原著(症例報告除く)
|
膵癌術後長期生存を得るための集学的治療戦略 2009/08
|
|
350.
|
原著(症例報告除く)
|
電子カルテシステムにおけるクリニカルパス管理とその運用-診療情報管理士と医療情報技師による医師･看護師のパスへの業務負担軽減の試み- 2009/06
|
|
351.
|
原著(症例報告除く)
|
Surgical results after preoperativechemoradiation therapy for patients with pancreatic cancer. 2009/04
|
|
352.
|
原著(症例報告除く)
|
Pre-operative patient selection of pancreatic cancer patients by multi-detector row CT 2009/03
|
|
353.
|
原著(症例報告除く)
|
A new guideline to reduce postoperative morbidity after pancreaticoduodenectomy. 2008/08
|
|
354.
|
総説
|
【癌治療クリニカルパスUpdate】 膵臓癌手術 2008/07
|
|
355.
|
症例報告
|
肝膿瘍に続発した細菌性眼内炎・腸腰筋膿瘍･脛骨骨髄炎の1例 2008/06
|
|
356.
|
原著(症例報告除く)
|
Neoadjuvant chemoradiation in patients with potentially resectable pancreatic
cancer. 2008/01
|
|
357.
|
原著(症例報告除く)
|
Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial. 2008
|
|
358.
|
その他
|
Long-term outcome of hepatocellular carcinoma patients who underwent liver resection using microwave tissue coagulation. 2008
|
|
359.
|
原著(症例報告除く)
|
Circulating dendritic cells and development of septic complications after pancreatectomy for pancreatic cancer. 2007/12
|
|
360.
|
原著(症例報告除く)
|
病院開院に伴う電子クリニカルパス導入とその後の経過についてー診療情報管理士の取り組みを中心に 2007/10
|
|
361.
|
原著(症例報告除く)
|
膵頭十二指腸切除術におけるクリニカルパス 2007/10
|
|
362.
|
症例報告
|
Inflammatory pseudotumors of the pancreas and liver with infiltration of IgG4-positive plasma cells. 2007/09
|
|
363.
|
原著(症例報告除く)
|
Postoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: clinical role of the no-margin resection. 2007/07
|
|
364.
|
原著(症例報告除く)
|
Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer. 2007/04
|
|
365.
|
原著(症例報告除く)
|
Clinical impact of multidetector row computed tomography on patients with pancreatic cancer. 2007/03
|
|
366.
|
原著(症例報告除く)
|
【画像診断による膵癌術前進行度診断 正診率の向上をめざして】 MD-CTによる進展度診断と外科的予後 2007/02
|
|
367.
|
原著(症例報告除く)
|
膵癌患者におけるmulti-detector row CTの臨床的影響 2007
|
|
368.
|
原著(症例報告除く)
|
Clinical monitoring of innate cellular immunity of monocytes/macrophages by tumor necrosis factor alpha productivity in whole blood stimulated by lipopolysaccharide in patients with pancreatic cancer. 2006/07
|
|
369.
|
原著(症例報告除く)
|
Less morbidity after pancreaticoduodenectomy of patients with pancreatic cancer 2006
|
|
370.
|
原著(症例報告除く)
|
Surgical influe.nce of pancreatectomy on the function and count of circulating dendritic cells in patients with pancreatic cancer. 2006
|
|
371.
|
原著(症例報告除く)
|
Using an internal thoracic artery holder in pancreaticojejunostomy 2006
|
|
372.
|
原著(症例報告除く)
|
【癌ワクチン療法の新しい試み】 膵癌におけるペプチド化学併用療法の開発に向けて 2006
|
|
373.
|
原著(症例報告除く)
|
【熟知すべき最近の画像診断;消化器癌の立体画像】 膵頭部癌の診断・治療におけるMDCTの役割 2006
|
|
374.
|
その他
|
Clinical outcome of 214 liver resevtion using microwave tissue coagulation 2005
|
|
375.
|
原著(症例報告除く)
|
Impaired function of circulating dendritic cells in patients with pancreatic cancer. 2005
|
|
376.
|
その他
|
Ｓｅｐｓｉｓに伴う急性肺障害に対する好中球エラスターゼ阻害薬の使用経験 2005
|
|
377.
|
原著(症例報告除く)
|
ハイドロファイバ-による術後離開創の治療効果 2005
|
|
378.
|
その他
|
膵菅癌の進達度診断 2005
|
|
379.
|
原著(症例報告除く)
|
C型肝炎併存胆管細胞癌の当施設における年次推移とその臨床的特徴 2004
|
|
380.
|
原著(症例報告除く)
|
Safety of hepatectomy for living donors as evaluated using asialoscintigraphy. 2004
|
|
381.
|
原著(症例報告除く)
|
Stenting of the superior mesenteric artery as a preoperative treatment for total pancreatectomy. 2004
|
|
382.
|
原著(症例報告除く)
|
腫瘤形成性膵炎の形態を呈した自己免疫性膵炎と考えられる1例 2004
|
|
383.
|
原著(症例報告除く)
|
当科での局所進行膵癌の術前放射線化学療法 2004
|
|
384.
|
原著(症例報告除く)
|
Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. 2003
|
|
385.
|
原著(症例報告除く)
|
Hepatocellular dysfunction induced by nitric oxide production in hepatocytes isolated from rats with sepsis. 2003
|
|
386.
|
原著(症例報告除く)
|
Prevention of pleural effusion following hepatectomy using argon beam coagulation. 2003
|
|
387.
|
原著(症例報告除く)
|
Refractoriness to platelet transfusion following partial hepatectomy for hepatocellular carcinoma: report of two cases. 2003
|
|
388.
|
原著(症例報告除く)
|
肝癌 肝細胞癌に対するmicrowave凝固療法を用いた肝切除術 根治切除症例の検討 2003
|
|
389.
|
原著(症例報告除く)
|
術後sepsisに併発した急性肺傷害に対し血液浄化療法で救命し得た3例 2003
|
|
390.
|
原著(症例報告除く)
|
Enhancement of circulating dendritic cell activity by immunomodulators (OK432 and KP-40). 2002
|
|
391.
|
原著(症例報告除く)
|
Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study. 2002
|
|
392.
|
原著(症例報告除く)
|
Increased nitric oxide production in hepatocytes is involved in liver dysfunction following obstructive jaundice. 2002
|
|
393.
|
原著(症例報告除く)
|
感悪性腫瘍に対するAblation Therapy 肝細胞癌に対するMicrowave凝固壊死療法を用いた肝切除術 根治切除例の検討 2002
|
|
394.
|
原著(症例報告除く)
|
The use of liver grafts from donors with bacterial meningitis. 2001
|
|
395.
|
その他
|
〜細菌性髄膜炎ドナ-を用いた脳死肝移植〜 適切な抗菌薬投与で安全に施行 2001
|
|
396.
|
原著(症例報告除く)
|
英国The Queen Elizabeth Hospital,The Liver Unitでの臨床経験 2001
|
|
397.
|
原著(症例報告除く)
|
進行胆嚢癌(stage IVa)長期生存の1例 2001
|
|
398.
|
原著(症例報告除く)
|
Increased extra domain-A containing fibronectin and hepatic dysfunction during septic response: An in vivo and in vitro study 2000/06
|
|
399.
|
原著(症例報告除く)
|
Nitric oxide production and hepatic dysfunction in patients with postoperative sepsis 2000/03
|
|
400.
|
原著(症例報告除く)
|
Ex vivo liver perfusion with arterial blood from a pig with ischemic liver failure 1999
|
|
5件表示
|
|
全件表示(400件)
|
